Changes in Red Blood Cell Membrane Properties: The Role of Metabolic Syndrome Components
Author:
Birulina Yu. G.1, Petrova I. V.1, Ivanov V. V.1, Buyko E. E.2, Shaibekova R. R.1, Grigoreva A. V.1, Kovalev I. V.1, Nosarev A. V.1, Gusakova S. V.1
Affiliation:
1. Siberian State MedicalUniversity, 2, MoscovskyTrakt, Tomsk, 634050, Russia 2. Siberian State MedicalUniversity, 2, MoscovskyTrakt, Tomsk, 634050, Russia, also with Tomsk Polytechnic University, 30, Lenina Ave., Tomsk, 634050, Russia
Abstract
Metabolic syndrome (MetS) is a cluster of metabolic, hormonal and hemodynamic disorders that contribute to a change in the structural and functional status of erythrocytes and contribute to dysregulation of their cation transport function, where Ca2+ -dependent potassium channels (KCa channels) play an important role. A MetS model was performed using male Wistar rats, which were divided into control and experimental groups. Rats in the control group were fed standard rat chow. Rats in the experimental group were exposed to a high-fat and high-carbohydrate (HFHC) diet for 12 weeks. The data obtained indicate that the HFHC diet led to obesity, high blood pressure, hyperglycemia, impaired glucose tolerance, and dyslipidemia. The level of glutathione (GSH) decreased in the erythrocytes of rats suffering from MetS, but the level of malondialdehyde (MDA) increased. It was shown that the amplitude of the membrane potential of erythrocytes of rats with MetS changed depending on the acting agent: when stimulated with calcium ionophore A23187 it decreased, when the redox system ascorbat –phenazine methosulfate was used, it increased compared to the control group. The data obtained indicate that a HFHC diet leads to changes in the physical and chemical properties of the erythrocyte membrane.
Publisher
North Atlantic University Union (NAUN)
Subject
General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering,General Medicine,Bioengineering
Reference28 articles.
1. M.G. Saklayen, “The Global Epidemic of the Metabolic Syndrome,” Curr. Hypertens. Rep. vol. 20, no. 2, pp. 12, 2018. 2. M.K. Lee, K. Han, M.K. Kim, E.S. Koh, E.S. Kim, G.E. Nam et al., “Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study,” Sci. Rep., vol. 10, no. 1, pp. 2313, 2020. 3. M.J. Fowler, “Microvascular and Macrovascular Complications of Diabetes,” Clinical Diabetes, vol. 2008, pp. 77–82, 2008. 4. A.F. Catoi, A.E. Parvu, A.D. Andreicut, A. Mironiuc, A. Craciun, C. Catoi et al., “Metabolically Healthy versus Unhealthy Morbidly Obese: Chronic Inflammation, Nitro-Oxidative Stress, and Insulin Resistance,” Nutrients, vol. 10, no. 9, pp. 1199, 2018. 5. F.V. Francisqueti, A.F. Nascimento, I.O. Minatel, M.C. Dias, R. Luvizotto, C. Berchieri-Ronchi et al., “Metabolic syndrome and inflammation in adipose tissue occur at different times in animals submitted to a high-sugar/fat diet,” J. Nutr. Sci., vol. 6, pp. e41. 2017.
|
|